Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2023-06-12 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
第三届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 14th meeting of the 3rd Supervisory Board of Nanjing Yaoshi Technology Co., Ltd. It details the approval of changes related to the management of raised funds and the use of bank acceptance bills for project funding. The document includes voting results and references other announcements for detailed information. The content is focused on supervisory board meeting decisions rather than full financial reports or earnings. The document length is short (1045 characters) and it serves as an official meeting resolution announcement rather than a full report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-12 Chinese
关于不向下修正药石转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Nanjing Yaoshi Technology Co., Ltd. regarding the decision not to downward adjust the conversion price of its convertible bonds (ticker 123145). It details the bond issuance, listing, conversion price adjustment clauses, and the board's decision after a specific period of stock price performance. The document is a formal disclosure about convertible bond terms and a board resolution, not a full financial report or earnings release. It is a regulatory announcement about capital structure and bond terms, specifically about convertible bond price adjustment. This fits best under Capital/Financing Update (CAP) as it relates to convertible bond pricing and financing terms updates.
2023-06-07 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2022 annual equity distribution (dividend) plan approved at the 2022 Annual General Meeting held on May 12, 2023. It details the dividend amount, record date, ex-dividend date, and related adjustments to convertible bond conversion price. The document is relatively short (2120 characters) and primarily serves to inform shareholders about the dividend distribution and related procedural details. It does not contain full financial statements or comprehensive financial performance data. Therefore, it is not an Annual Report (10-K) or Interim Report (IR). It is also not a Notice of Dividend Amount (DIV) in the strict sense because it is an implementation announcement following the AGM approval, but given the content focuses on dividend distribution details, it fits best under Notice of Dividend Amount (DIV).
2023-06-05 Chinese
关于2022年年度权益分派调整可转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Nanjing Yaoshi Technology Co., Ltd. regarding the adjustment of the conversion price of its convertible bonds (referred to as 'Yaoshi Convertible Bonds'). It details the previous and adjusted conversion prices, the basis for the adjustment, the formula used, and the effective date of the new conversion price. The content focuses on a capital/financing update related to convertible bond terms and does not contain financial statements or comprehensive financial performance data. The document length is short (1456 characters) and is clearly an announcement about a financing instrument's terms adjustment rather than a full report or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-06-05 Chinese
关于药石转债可能触发向下修正转股价格条件的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding a potential downward adjustment of the conversion price of its convertible bonds. It includes details about the bond issuance, trading codes, adjustment conditions, and regulatory compliance. The text is an informative notice about a possible triggering event for price adjustment and the related procedures, rather than a full financial report or detailed financial statements. It is not an annual or interim report, earnings release, or audit report. It is also not a call transcript, management change, or merger announcement. The document is a regulatory announcement informing investors about a potential capital/financing event (adjustment of convertible bond conversion price) and the company's planned disclosure and procedural steps. Therefore, it fits best under Capital/Financing Update (CAP). The document length is under 5,000 characters but contains substantive information about financing terms and conditions, not merely a report publication announcement or a brief notice. Hence, the classification is CAP with high confidence.
2023-05-31 Chinese
关于完成变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration changes and the issuance of a new business license for the company. It references prior announcements about changes in business scope, registered capital, and company articles, but this document itself is a formal notice of the completion of these administrative changes. It does not contain financial statements, audit information, or detailed report content. The document length is short (960 characters) and it serves as an official announcement of a corporate registration update rather than a financial or management report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.